118 related articles for article (PubMed ID: 25191796)
41. A high percentage of skin melanoma cells expresses SPANX proteins.
Salemi M; Calogero AE; Vicari E; Migliore E; Zaccarello G; Cosentino A; Amore M; Tricoli D; Castiglione R; Bosco P; Rappazzo G
Am J Dermatopathol; 2009 Apr; 31(2):182-6. PubMed ID: 19318807
[TBL] [Abstract][Full Text] [Related]
42. Cell cycle and apoptosis regulators in Spitz nevi: comparison with melanomas and common nevi.
Stefanaki C; Stefanaki K; Antoniou C; Argyrakos T; Patereli A; Stratigos A; Katsambas A
J Am Acad Dermatol; 2007 May; 56(5):815-24. PubMed ID: 17437889
[TBL] [Abstract][Full Text] [Related]
43. The use of elastin immunostain improves the evaluation of melanomas associated with nevi.
Kamino H; Tam S; Tapia B; Toussaint S
J Cutan Pathol; 2009 Aug; 36(8):845-52. PubMed ID: 19032378
[TBL] [Abstract][Full Text] [Related]
44. Fluorescence in situ hybridization for distinguishing nevoid melanomas from mitotically active nevi.
Gerami P; Wass A; Mafee M; Fang Y; Pulitzer MP; Busam KJ
Am J Surg Pathol; 2009 Dec; 33(12):1783-8. PubMed ID: 19809275
[TBL] [Abstract][Full Text] [Related]
45. Diagnostic and Prognostic Value of ProEx C and GLUT1 in Melanocytic Lesions.
Yan S; Coffing BN; Li Z; Xie H; Brennick JB; Beg HA; Froehlich HM; Wells WA
Anticancer Res; 2016 Jun; 36(6):2871-80. PubMed ID: 27272799
[TBL] [Abstract][Full Text] [Related]
46. Dermoscopic features of common nevi: a review.
Kim JK; Nelson KC
G Ital Dermatol Venereol; 2012 Apr; 147(2):141-8. PubMed ID: 22481577
[TBL] [Abstract][Full Text] [Related]
47. Large-scale proteomic characterization of melanoma expressed proteins reveals nestin and vimentin as biomarkers that can potentially distinguish melanoma subtypes.
Qendro V; Lundgren DH; Rezaul K; Mahony F; Ferrell N; Bi A; Latifi A; Chowdhury D; Gygi S; Haas W; Wilson L; Murphy M; Han DK
J Proteome Res; 2014 Nov; 13(11):5031-40. PubMed ID: 25322343
[TBL] [Abstract][Full Text] [Related]
48. Identification of a Robust Methylation Classifier for Cutaneous Melanoma Diagnosis.
Conway K; Edmiston SN; Parker JS; Kuan PF; Tsai YH; Groben PA; Zedek DC; Scott GA; Parrish EA; Hao H; Pearlstein MV; Frank JS; Carson CC; Wilkerson MD; Zhao X; Slater NA; Moschos SJ; Ollila DW; Thomas NE
J Invest Dermatol; 2019 Jun; 139(6):1349-1361. PubMed ID: 30529013
[TBL] [Abstract][Full Text] [Related]
49. Prognostic Significance of Nuclear Phospho-ATM Expression in Melanoma.
Bhandaru M; Martinka M; McElwee KJ; Rotte A
PLoS One; 2015; 10(8):e0134678. PubMed ID: 26275218
[TBL] [Abstract][Full Text] [Related]
50. Characterization of malignant melanoma using vibrational spectroscopy.
Hammody Z; Sahu RK; Mordechai S; Cagnano E; Argov S
ScientificWorldJournal; 2005 Mar; 5():173-82. PubMed ID: 15798877
[TBL] [Abstract][Full Text] [Related]
51. Melanoma coexisting with solar elastosis: a potential pitfall in the differential diagnosis between nevus and melanoma.
Konopinski JC; Danialan R; Torres-Cabala CA; Tetzlaff MT; Nagarajan P; Curry JL; Ivan D; Prieto VG; Aung PP
Hum Pathol; 2019 Feb; 84():270-274. PubMed ID: 30359637
[TBL] [Abstract][Full Text] [Related]
52. Identification and analysis of an early diagnostic marker for malignant melanoma: ZAR1 intra-genic differential methylation.
Shinojima Y; Terui T; Hara H; Kimura M; Igarashi J; Wang X; Kawashima H; Kobayashi Y; Muroi S; Hayakawa S; Esumi M; Fujiwara K; Ghosh S; Yamamoto T; Held W; Nagase H
J Dermatol Sci; 2010 Aug; 59(2):98-106. PubMed ID: 20654783
[TBL] [Abstract][Full Text] [Related]
53. Comparative Quantitative Proteomic Analysis of Melanoma Subtypes, Nevus-Associated Melanoma, and Corresponding Nevi.
Naimy S; Sølberg JBK; Kuczek DE; Løvendorf MB; Bzorek M; Litman T; Mund A; Rahbek Gjerdrum LM; Clark RA; Mann M; Dyring-Andersen B
J Invest Dermatol; 2024 Jan; ():. PubMed ID: 38185415
[TBL] [Abstract][Full Text] [Related]
54. Strategies for early melanoma detection: Approaches to the patient with nevi.
Goodson AG; Grossman D
J Am Acad Dermatol; 2009 May; 60(5):719-35; quiz 736-8. PubMed ID: 19389517
[TBL] [Abstract][Full Text] [Related]
55. Duplex Ratio Tests as Diagnostic Biomarkers in Malignant Melanoma.
Moore DA; Saldanha G; Ehdode A; Mughal MZ; Potter L; Dyall L; Pringle JH
J Mol Diagn; 2015 Sep; 17(5):616-22. PubMed ID: 26134170
[TBL] [Abstract][Full Text] [Related]
56. Spindle and epitheloid cell nevi in the adult. Clinicopathologic report of 26 cases.
Echevarria R; Ackerman LV
Cancer; 1967 Feb; 20(2):175-89. PubMed ID: 6019359
[No Abstract] [Full Text] [Related]
57. MicroRNA Ratios Distinguish Melanomas from Nevi.
Torres R; Lang UE; Hejna M; Shelton SJ; Joseph NM; Shain AH; Yeh I; Wei ML; Oldham MC; Bastian BC; Judson-Torres RL
J Invest Dermatol; 2020 Jan; 140(1):164-173.e7. PubMed ID: 31580842
[TBL] [Abstract][Full Text] [Related]
58. Expression of HSP 90, PTEN and Bcl-2 in conjunctival melanoma.
Westekemper H; Karimi S; Süsskind D; Anastassiou G; Freistühler M; Steuhl KP; Bornfeld N; Schmid KW; Grabellus F
Br J Ophthalmol; 2011 Jun; 95(6):853-8. PubMed ID: 20956280
[TBL] [Abstract][Full Text] [Related]
59. HSP90 as a marker of progression in melanoma.
McCarthy MM; Pick E; Kluger Y; Gould-Rothberg B; Lazova R; Camp RL; Rimm DL; Kluger HM
Ann Oncol; 2008 Mar; 19(3):590-4. PubMed ID: 18037622
[TBL] [Abstract][Full Text] [Related]
60. Assessing Skin Cancer Using Epidermal Genetic Information Retrieved by Adhesive Patch Skin Surface Sampling.
Lee N; Scope A; Rabinovitz H
Dermatol Clin; 2017 Oct; 35(4):521-524. PubMed ID: 28886808
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
